StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) income statement

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.46−0.04 (-1.60%)

Close on Nov 19, 2026Market cap $23.03MP/E –Yield –

See a number that looks wrong?